Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Wong, Karen K., Davey, Richard T., Hewlett, Angela L., Kraft, Colleen S., Mehta, Aneesh K., Mulligan, Mark J., Beck, Allison, Dorman, William, Kratochvil, Christopher J., Lai, Lilin, Palmore, Tara N., Rogers, Susan, Smith, Philip W., Suffredini, Anthony F., Wolcott, Mark, Ströher, Ute, Uyeki, Timothy M.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946014/
https://ncbi.nlm.nih.gov/pubmed/27118786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw256
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires